2025 · 1st Quarter (Jan 1 - Mar 31)

STEALTH BIOTHERAPEUTICS INC.

Filed by STEALTH BIOTHERAPEUTICS INC..

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 22, 2025
Income: Not reported
Expenses: $50,000.00
Registrant: STEALTH BIOTHERAPEUTICS INC.
Client: STEALTH BIOTHERAPEUTICS INC.
Filing UUID: fd777c07-2abd-453d-a811-3c50dc317bb3
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

H.R. 7384/S. 4583, the Creating Hope Reauthorization Act of 2024 (118th Congress) H.R. 1509/S. 752 the Accelerating Kids Access to Care Act H.R. 1262/S. 932 - Give Kids a Chance Act of 2025 General discussions about ultra-rare disease drug development General discussions about regulatory reform, including scientific-focused drug development meetings H.R. 1092/S. 526, the BENEFIT Act (118th Congress) General discussions about mitochondrial diseases H.R. 1532/S. 822, the Scientific EXPERT Act of 2025 General discussions about ultra-rare diseases FDA Rare Disease Innovation Hub

Literal federal measure citations: H.R. 7384, S. 4583, H.R. 1509, S. 752, H.R. 1262, S. 932, H.R. 1092, S. 526, H.R. 1532, S. 822

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.